Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia
Author(s) -
JinSook Ryu,
C.-W. Lee,
Ki Hwan Hong,
J.-A. Shin,
SungHoon Lim,
C.-S. Park,
Ju Hyun Shim,
KyungOk Nam,
KwiSook Choi,
YoungHoon Kim,
Ki Hoon Han
Publication year - 2007
Publication title -
cardiovascular research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.774
H-Index - 219
eISSN - 1755-3245
pISSN - 0008-6363
DOI - 10.1093/cvr/cvm067
Subject(s) - angiogenesis , neovascularization , cx3cr1 , kinase insert domain receptor , vascular endothelial growth factor , cancer research , vascular endothelial growth factor a , biology , chemokine , immunology , chemokine receptor , inflammation , vegf receptors
The present study investigated the detailed mechanism by which fractalkine (Fkn), a CX3C chemokine, induces angiogenesis and its functional implication in alleviating ischaemia in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom